Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000875320-25-000148)

Filing Details

Accession Number:: 0000875320-25-000148
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-12 16:11:46
Reporting Period:: 2025-03-10

Filing Date:: 2025-03-12
Accepted Time:: 2025-03-12 16:11:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1223348	Jr F Charles Wagner	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp & Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-03-10	3,298	$500.00	51,671	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.